Balance Sheet - Taysha Gene Therapies, Inc. (TSHA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 319.77 | 139.04 | 143.94 | 87.88 | 149.10 | 251.25 | 0.00 |
| Other current assets | 4.88 | 3.09 | 5.93 | 8.54 | 10.50 | 6.63 | 0.02 |
| Total current assets | 324.65 | 142.13 | 149.87 | 96.42 | 159.60 | 257.88 | 0.02 |
| Total non-current assets | 18.67 | 18.23 | 22.86 | 29.86 | 54.35 | 1.00 | 0.02 |
| Total assets | 343.32 | 160.36 | 172.73 | 126.28 | 213.96 | 258.88 | 0.02 |
| Total current liabilities | 26.55 | 26.23 | 36.76 | 62.79 | 51.75 | 7.13 | 0.15 |
| Total non-current liabilities | 69.83 | 62.61 | 61.04 | 62.54 | 66.83 | 0.45 | 0.00 |
| Total liabilities | 96.38 | 88.84 | 97.79 | 125.33 | 118.57 | 7.58 | 0.15 |
| Total stockholders' equity | 246.94 | 71.53 | 74.94 | 0.95 | 95.38 | 251.30 | -0.14 |
| Common shares outstanding | 320 | 250 | 116 | 44 | 38 | 18 | 37 |
Show Quarterly Balance Sheet
Balance Sheet - Taysha Gene Therapies, Inc. (TSHA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 276.58 | 319.77 | 297.34 | 312.76 | 116.59 | 139.04 | 157.69 | 172.74 | 123.98 | 143.94 | 164.28 | 45.08 | 63.43 | 87.88 | 34.31 | 66.24 | 96.63 | 149.10 | 188.79 | 197.37 | 228.68 | 251.25 | 278.63 | 11.20 | 0.00 | 0.00 |
| Other current assets | 5.67 | 4.88 | 2.61 | 3.50 | 4.12 | 3.09 | 3.87 | 5.73 | 6.62 | 5.93 | 7.53 | 9.03 | 8.93 | 8.54 | 8.70 | 10.60 | 10.26 | 10.50 | 8.39 | 9.93 | 10.95 | 6.63 | 0.60 | 0.10 | 0.09 | |
| Total current assets | 282.25 | 324.65 | 299.95 | 316.26 | 120.71 | 142.13 | 161.56 | 178.47 | 130.60 | 149.87 | 171.81 | 54.12 | 72.36 | 96.42 | 43.00 | 76.84 | 106.89 | 159.60 | 197.17 | 207.30 | 239.63 | 257.88 | 279.24 | 11.30 | 11.30 | |
| Total non-current assets | 18.10 | 18.67 | 16.60 | 17.07 | 17.65 | 18.23 | 18.66 | 21.92 | 22.40 | 22.86 | 23.96 | 27.43 | 29.24 | 29.86 | 68.47 | 65.50 | 59.09 | 54.35 | 43.87 | 34.56 | 3.20 | 1.00 | 0.03 | 0.02 | ||
| Total assets | 300.35 | 343.32 | 316.55 | 333.33 | 138.36 | 160.36 | 180.22 | 200.39 | 153.00 | 172.73 | 195.77 | 81.54 | 101.60 | 126.28 | 111.47 | 142.33 | 165.98 | 213.96 | 241.04 | 241.86 | 242.83 | 258.88 | 279.27 | 11.32 | ||
| Total current liabilities | 20.10 | 26.55 | 28.63 | 25.35 | 22.56 | 26.23 | 29.34 | 34.18 | 38.64 | 36.76 | 180.45 | 50.64 | 54.46 | 62.79 | 33.14 | 42.95 | 48.62 | 51.75 | 43.21 | 28.39 | 18.96 | 7.13 | 11.62 | 20.09 | 20.09 | |
| Total non-current liabilities | 68.31 | 69.83 | 68.93 | 59.26 | 60.75 | 62.61 | 62.09 | 57.35 | 60.51 | 61.04 | 64.43 | 68.02 | 62.09 | 62.54 | 67.20 | 66.67 | 66.63 | 66.83 | 57.43 | 26.97 | 1.00 | 0.45 | 8.84 | 1.25 | ||
| Total liabilities | 88.41 | 96.38 | 97.57 | 84.60 | 83.30 | 88.84 | 91.42 | 91.53 | 99.15 | 97.79 | 244.88 | 118.66 | 116.55 | 125.33 | 100.34 | 109.62 | 115.25 | 118.57 | 100.65 | 55.37 | 19.96 | 7.58 | 11.62 | 20.09 | ||
| Total stockholders' equity | 211.94 | 246.94 | 218.99 | 248.73 | 55.06 | 71.53 | 88.80 | 108.87 | 53.85 | 74.94 | -49.11 | -37.11 | -14.95 | 0.95 | 11.13 | 32.71 | 50.73 | 95.38 | 140.39 | 186.50 | 222.87 | 251.30 | 267.64 | -8.77 | -0.14 | |
| Common shares outstanding | 367 | 320 | 353 | 298 | 269 | 205 | 268 | 233 | 231 | 187 | 126 | 64 | 63 | 56 | 41 | 40 | 38 | 38 | 38 | 37 | 37 | 38 | 12 | 35 | 15 | 15 |